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To the Editor: Borrelia miyamotoi 
is a relatively novel tickborne relapsing 
fever spirochete, and is a different spe-
cies than B. burgdorferi sensu lato, the 
causative pathogen of Lyme borreliosis 
(1). B. miyamotoi was first isolated in 
1995 from Ixodes persulcatus ticks in 
Japan, after which it was detected in 
ticks in North America, Europe, and 
Russia (1,2). B. miyamotoi infections 
among humans were first reported in 
Russia in 2011 (3), and in 2013 in the 
United States (4). Recently, the first 
patient infected with B. miyamotoi was 
reported in the Netherlands (5). Condi-
tions reported to be associated with B. 
miyamotoi infection were systemic, 
including malaise and fever, menin-
goencephalitis, and neurologic symp-
toms. Because of the nature of these 
manifestations and because regular 
diagnostic tests for B. burgdorferi will 
most probably not detect B. miyamotoi 
infections (3,5), B. miyamotoi infec-
tions may remain undiagnosed. Nev-
ertheless, the relationship between B. 
miyamotoi infection and illness is not 
very well established; the case-patients 
reported, including the patient in the 
Netherlands, were usually hospitalized, 
severely ill, and often immunocom-
promised (3–5). The extent to which 
B. miyamotoi causes infection and 
disease in immunocompetent persons 
is unknown. As a first step to indicate 
the population at risk for infection, we 
investigated human exposure to B. mi-
yamotoi in the Netherlands.
To do this, we assessed the B. mi-
yamotoi infection rate of ticks that had 
bitten humans. Earlier studies included 
ticks collected through flagging an area 
(1,2); our study provides specific infor-
mation about the infection rate of ticks 
feeding on humans. The ticks were 
collected from persons who reported 
their tick bites on the website http://
www.tekenradar.nl. After removal of 
the ticks from the skin, the ticks were 
submitted to the National Institute of 
Public Health and the Environment. 
For 1,040 ticks gathered during April–
June 2012, we determined tick species, 
stage of development, and gender by 
microscopic examination.
We defined the degree of engorge-
ment in 4 categories from unengorged 
(score 0) to fully engorged (score 3), as 
visually determined. To isolate DNA, 
we boiled the ticks with engorgement 
scores of 0–1 in ammonium hydroxide 
(6); for ticks with engorgement scores 
of 2–3, we used the QIAGEN (Valen-
cia, CA . USA) blood and tissue DNA-
extraction kit (7). We used a B. miya-
motoi–specific real-time PCR based on 
the flagellin gene for detection of the 
bacteria (5). Quantitative PCR-positive 
tick lysates were tested with a conven-
tional PCR, which amplifies a fragment 
of glycerophosphodiester phosphodies-
terase (glpQ) gene, to confirm the out-
come (5). These PCR products were 
sequenced and were identical to B. 
miyamotoi sequences filed in GenBank 
(AB824855). We determined the pres-
ence of B. burgdorferi DNA with a du-
plex quantitative PCR using fragments 
of the outer membrane protein A gene 
and the flagellin B gene as targets (7).
All 1,040 ticks were identified as 
Ixodes ricinus, the most common tick 
that transmits B. burgdorferi in northern 
Europe (8). We detected B. miyamotoi 
DNA in 37 ticks (3.6%) using real-time 
PCR targeting the flagellin gene, which 
was confirmed for 32 ticks (3.1%) in 
the conventional PCR targeting the 
glpQ gene. (online Technical Appen-
dix Table, http://wwwnc.cdc.gov/EID/
article/20/7/13-1525-Techapp1.pdf). 
In 9 of the 37 ticks positive for B. mi-
yamotoi, B. burgdorferi was also de-
tected. Similar to B. burgdorferi, the 
risk of transmission of B. miyamotoi 
is likely to become higher if ticks be-
come engorged with blood; 23 of the 37 
(62.2%) B. miyamotoi–infected ticks 
were somewhat engorged (score 1–3) 
and thus had such an increased risk for 
transmission. All glpQ sequences of 
the detected B. miyamotoi isolates were 
identical to the sequence detected in 
the sample from the patient reported in 
the Netherlands by Hovius et al. (5). B. 
burgdorferi DNA was detected in 190 
ticks (18.3%) compared with 11.8% 
detected in a study that included ticks 
collected through flagging (9). 
Ticks included in the study were 
submitted from all parts of the country; 
B. miyamotoi– and B. burgdorferi–
positive ticks were found in almost ev-
ery region (Figure). Of the ≈1 million 
tick bites per year in the Netherlands 
(10), an estimated 36,000 were by ticks 
that were infected with B. miyamotoi, 
and 183,000 were by ticks infected 
with B. burgdorferi. This substantial 
human exposure to B. miyamotoi and 
the reported cases in Russia, the United 
States, and, recently, the Netherlands 
(3–5) raises the question to what extent 
exposure to B. miyamotoi leads to hu-
man disease in the general population. 
These results call for the development 
of sensitive and specific serologic and 
molecular tests for B. miyamotoi to 
identify possible patients, which will 
lead to a better understanding of the 
clinical spectrum of B. miyamotoi–in-
duced disease.
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Figure.	 Locations	 of	 ticks	 collected	 through	 the	 website	 http://www.tekenradar.nl	 in	 the	
Netherlands	 during	 summer	 2012,.	Ticks	 included	 in	 the	 study	were	 submitted	 from	all	
parts	of	the	country;	ticks	positive	for	Borrelia miyamotoi	and	B.	burgdorferi	were	found	in	
almost	every	region.	
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